KR100512820B1 - Compositions and Methods for the Treatment of Tumor - Google Patents
Compositions and Methods for the Treatment of TumorInfo
- Publication number
- KR100512820B1 KR100512820B1 KR10-2004-7011453A KR20047011453A KR100512820B1 KR 100512820 B1 KR100512820 B1 KR 100512820B1 KR 20047011453 A KR20047011453 A KR 20047011453A KR 100512820 B1 KR100512820 B1 KR 100512820B1
- Authority
- KR
- South Korea
- Prior art keywords
- tumor
- compositions
- treatment
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13345999P | 1999-05-11 | 1999-05-11 | |
US60/133,459 | 1999-05-11 | ||
PCT/US2000/003565 WO2001053486A1 (en) | 1999-03-08 | 2000-02-11 | Compositions and methods for the treatment of tumor |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2001-7011391A Division KR100512819B1 (en) | 1999-03-08 | 2000-02-11 | Compositions and Methods for the Treatment of Tumor |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2004-7019194A Division KR20050004241A (en) | 1999-05-11 | 2000-02-11 | Compositions and Methods for the Treatment of Tumor |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20040073587A KR20040073587A (en) | 2004-08-19 |
KR100512820B1 true KR100512820B1 (en) | 2005-09-07 |
Family
ID=33538658
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2004-7011453A KR100512820B1 (en) | 1999-05-11 | 2000-02-11 | Compositions and Methods for the Treatment of Tumor |
KR10-2004-7019194A KR20050004241A (en) | 1999-05-11 | 2000-02-11 | Compositions and Methods for the Treatment of Tumor |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2004-7019194A KR20050004241A (en) | 1999-05-11 | 2000-02-11 | Compositions and Methods for the Treatment of Tumor |
Country Status (2)
Country | Link |
---|---|
KR (2) | KR100512820B1 (en) |
NZ (1) | NZ523209A (en) |
-
2000
- 2000-02-11 NZ NZ52320900A patent/NZ523209A/en unknown
- 2000-02-11 KR KR10-2004-7011453A patent/KR100512820B1/en not_active IP Right Cessation
- 2000-02-11 KR KR10-2004-7019194A patent/KR20050004241A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20050004241A (en) | 2005-01-12 |
NZ523209A (en) | 2004-12-24 |
KR20040073587A (en) | 2004-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003200722A1 (en) | Compositions and methods for the treatment of tumor | |
AU2003200731A1 (en) | Compositions and methods for the treatment of tumor | |
AU2003200740A1 (en) | Compositions and methods for the treatment of tumor | |
AU2495200A (en) | Compositions and methods for the treatment of tumor | |
AU6147401A (en) | Compositions and methods for the treatment of cancer | |
AU2212299A (en) | Compositions and methods for the treatment of tumor | |
KR100510795B1 (en) | Compositions and Methods for the Treatment of Tumor | |
MXPA02004770A (en) | Therapeutic compositions and methods of use thereof. | |
HUP0201436A2 (en) | Methods and compositions for treating solid tumors | |
AU4205100A (en) | Methods and compositions for the treatment of pancreatitis | |
HUP0104688A3 (en) | Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer | |
ZA200301204B (en) | Compositions and methods for the diagnosis and treatment of tumor | |
PL352931A1 (en) | Compositions and uses of et743 for treating cancer | |
IL148579A0 (en) | Oncolytic combinations for the treatment of cancer | |
AU8678501A (en) | Compositions and methods for the diagnosis and treatment of tumor | |
IL158206A0 (en) | Compositions and methods for the prevention and treatment of human prostate cancer | |
IL141426A0 (en) | Compositions and methods for the treatment of tumor | |
IL124650A0 (en) | Methods and therapeutic compositions for treating cancer | |
IL143212A0 (en) | Compositions and methods for the treatment of tumor | |
PL368035A1 (en) | Compositions and methods for the treatment of cancer | |
PL350863A1 (en) | Compositions and methods for the treatment and diagnosis of breast cancer | |
IL147410A0 (en) | L-acetylcarnitine and l-propionylcarnitine containing composition for the prevention and treatment of kidney dysfunctions and diseases | |
IL141551A0 (en) | Compositions and methods for the treatment of immune related diseases | |
IL149281A0 (en) | Treatment of cancer | |
KR100511819B1 (en) | Compositions and Methods for the Treatment of Tumor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A107 | Divisional application of patent | ||
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
A107 | Divisional application of patent | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
AMND | Amendment | ||
J201 | Request for trial against refusal decision | ||
E902 | Notification of reason for refusal | ||
B701 | Decision to grant | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20100825 Year of fee payment: 6 |
|
LAPS | Lapse due to unpaid annual fee |